Science-based startups are playing a crucial role in proactively bringing technologies for combatting COVID 19 to the people and helping the nation deal with the pandemic.As researchers, industrialists and entrepreneurs synergized their capabilities
Teledyne Acquires FLIR for More Than $8 Billion
Author:
May 19, 2021
Teledyne Technologies announced that it acquired FLIR Systems in a stock and cash transaction totaling approximately $8.2 billion, including net debt.
The deal was approved and adopted at stockholder meetings held by each company. FLIR will be part of Teledyne’s Digital Imaging segment under the name Teledyne FLIR.
“As a combined company, Teledyne FLIR will uniquely provide a full spectrum of imaging technologies and products spanning X-ray through infrared and from components to complete imaging systems,” Teledyne executive chairman Robert Mehrabian
said in a statement. “Teledyne FLIR will also provide a complete range of unmanned systems and imaging payload across all domains ranging from deep sea to deep space.”
Teledyne Acquires FLIR marinelink.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marinelink.com Daily Mail and Mail on Sunday newspapers.
CureMetrix
cmAssist by CureMetrix helps radiologists by identifying, marking and scoring regions of interest on screening mammograms
Improving sensitivity and specificity, cmAssist AI-CAD acts as a ‘second pair of eyes’ for the radiologist, delivering efficiency and more accurate detection of breast cancer for the women of Brazil.” Alyssa Watanabe, MD, FACR, Chief Medical Officer CureMetrix
SAN DIEGO, CA, USA, May 12, 2021 /EINPresswire.com/ CureMetrix, Inc., a global healthcare technology company that develops AI-driven software for radiology, announced it has received approval from Brazil’s Agência Nacional de Vigilância Sanitária (ANVISA) for cmAssist
®, its proprietary AI-based detection software for mammography. This ANVISA registration 81464750084 allows CureMetrix to market cmAssist to radiology practices and hospitals in Brazil.
Search jobs RFID in Pharmaceuticals Market Filliped by the Rising Demand for more Efficient Anti-Counterfeit Solutions
Future Market Insights (FMI), in its new study, finds that the radio-frequency identification (RFID) in pharmaceuticals market was valued at over US$ 950 Mn in 2018, and is estimated to register a Y-o-Y growth at approximately 10% in 2019. Prospects remain remarkable for the RFID in pharmaceuticals industry, as efficiency-led actions of players continue to enhance the reliability and accuracy of their business operations.
The study finds that drug tracing system remains the most lucrative application of RFID in pharmaceutical industry, accounting for approximately 60% sales. Efforts of the FDA, in collaboration with pharmaceutical suppliers, to maintain a secure drug supply in the wake of rising counterfeit drugs prevalence, has encouraged the pharmaceutical industry to use RFID in combination with the electronic product code (EPC) for